Microglia are resident myeloid cells of the CNS and participate both in normal CNS function and in the progression and resolution of disease. If a unique microglial gene and microRNA signature were identified, it would provide a basis for both understanding microglia biology and modulating microglia in the treatment of CNS diseases. Related to this, the investigation of microglia has been complicated by controversy and nomenclature disputes [1] [2] [3] , and the development of markers that distinguish microglia from hematogenous infiltrating macrophages, which have identical morphologies, has been a challenge for investigators 2 .
r e S O u r C e Microglia are resident myeloid cells of the CNS and participate both in normal CNS function and in the progression and resolution of disease. If a unique microglial gene and microRNA signature were identified, it would provide a basis for both understanding microglia biology and modulating microglia in the treatment of CNS diseases. Related to this, the investigation of microglia has been complicated by controversy and nomenclature disputes [1] [2] [3] , and the development of markers that distinguish microglia from hematogenous infiltrating macrophages, which have identical morphologies, has been a challenge for investigators 2 .
Recent studies suggest that resident microglia represent a unique, indigenous cell population in the brain. Specifically, it has been shown that adult microglia are derived from primitive macrophages 4 in a Myb-independent manner 5 via PU.1-and IRF8-dependent pathways 6 . This lineage is mainly regulated by CSFR1 (ref. 4) and its ligand, IL-34 (ref. 7) . In addition, it has been reported that in the experimental autoimmune encephalomyelitis (EAE) model, infiltrating monocytes do not contribute to the residual microglial pool 8 and that microglia can be distinguished from monocytes using red-green mice in which microglia and monocyte-derived macrophages are labeled with CX3CR1 (GFP) and CCR2 (RFP), respectively 9 . Thus, there is a resident pool of microglia that is separate from the peripheral myeloid cells that infiltrate the nervous system.
We embarked on a series of investigations to identify unique biological features of microglial cells using gene and microRNA array analysis and quantitative proteomic analysis. Using these two approaches, we profiled murine CNS-derived adult microglia versus splenic Ly6C monocyte subsets and other immune cell types. Our results identify a unique TGF-β-dependent microglial signature in mice, features of which were also observed in human microglial cells.
RESULTS

Identification of a unique microglial signature
To identify a unique microglia signature, we performed gene profiling and quantitative mass spectrometry analysis ( Supplementary Fig. 1 ) of CD11b + CD45 Low microglia isolated from the CNS and CD11b + Ly6C + monocyte subsets isolated from the spleen of naive adult mice. We chose Ly6C + monocytes, as this subset is known to be recruited to the CNS in association with inflammation [10] [11] [12] . Gene array identified 1,572 genes that were enriched in microglia (Fig. 1a,b) . Next, we performed quantitative mass spectrometry analysis (tandem mass tagging, TMT) of microglial cells versus splenic Ly6C Hi and Ly6C Low subsets. Mass spectrometry identified a total of 1,991 proteins ( Supplementary Fig. 1a,b) . We found that 1,381 of these proteins were differentially expressed between microglia and Ly6C subsets (Fig. 1c) . Of the 1,381 identified proteins, 455 were enriched in microglia and 926 (greater than twofold difference) were enriched in Ly6C monocytes. Figure 1d is a three dimensional scatterplot based on these 1381 proteins which shows a proteomic signature of microglia versus Ly6C subsets in which we highlight five highly expressed microglial proteins in the scatterplot: P2ry12, Lgmn, Tppp, Bin1 and Rgs10. We identified a total of 74 proteins that were uniquely expressed in microglia, including P2ry12, Lgmn, Tppp, Bin1 and Rgs10 ( Fig. 1d and Supplementary Fig. 1c ). In addition, of the 103 proteins that were enriched by more than fivefold in microglia Fig. 1d ), 64 were also identified in gene profiling of microglia. To investigate the degree to which the microglial molecules that we identified were expressed in other immune cell types and organ-specific macrophages, we constructed a Nanostring chip that contained 354 microglial enriched genes, 40 inflammation-related genes that we previously found to be altered in the microglia of SOD1 mice 12 and 6 housekeeping genes. We termed this chip MG400. We chose 254 genes from 1,572 genes and 100 proteins from 455 proteins, all of which were specifically or highly expressed in adult mouse microglia. We found 239 genes that were specifically expressed by microglia and 81 genes that were expressed by both microglia and organ-specific F4/80 + CD11b + macrophages (Fig. 1e) . A heat map and hierarchical clustering of microglia, organ-specific macrophages and immune cell populations analyzed with the MG400 chip revealed that the top microglial molecules grouped according to cell localization and function (Fig. 1f) .
We then performed quantitative RT-PCR (qPCR) analysis of six selected microglial genes to validate their expression in different cell populations (Fig. 1g) . We found minimal, if any, expression of these six microglial genes in other immune cells or organ-specific macrophages. Finally, to determine whether there was similar expression of these genes in human microglia, we performed qPCR in both fetal and adult human CNS-derived microglia and human blood-derived CD14 + CD16 − and CD14 + CD16 + monocytes, which are analogous to murine Ly6C Hi and Ly6C Low subsets 13 . We found that P2ry12, Gpr34, Mertk, C1qa, Pros1 and Gas6 were highly or uniquely expressed in human microglia (Fig. 1h) . Of note, there is no ortholog of Fcrls in humans, the most highly expressed gene in murine microglia. In summary, we identified genes (for example, Fcrls, P2ry12, Tmem119, Olfml3, Hexb, Tgfbr1, Gpr34 and Sall1) that appeared to be expressed in microglia, as we did not detect them in immune cells, Ly6C monocytes or organ-specific macrophages (Fig. 1f) . Recent work has shown that all tissue-resident macrophages are different to an extent, yet cluster together when compared with monocytes and dendritic cells, and that spleen red pulp macrophages are closely associated with microglia 14 . Consistent with this, we found that red pulp macrophages are the tissue-resident macrophages most similar to microglia (Fig. 1f) . In addition, we found that genes related to the TAM system (for example, Mertk, Pros1 and Gas6) were highly expressed in microglia (Fig. 1g) . It is well known that TAM family receptors and ligands are expressed in macrophages 15 . Furthermore, we found increased microglial expression of the C1q, Csfr1 and Cd34 genes, which are known to be expressed on tissue-resident macrophages 14 .
Thus, it appears that there are common features between CNS resident microglia and tissue macrophages. Our findings are consistent with reports that macrophage progenitors develop from the primitive ectoderm of the yolk sac 4 and give rise to tissue macrophages that do not have a monocytic progenitor 16, 17 .
Next, we investigated whether the microglial genes that we identified were expressed in CNS cells, including astrocytes, oligodendrocytes and neurons, by profiling these CNS cells with the MG400 microglial chip. Using unsupervised hierarchical clustering of CNS cell types and principal component analysis (PCA) of the MG400 gene expression profile, we found that microglia were different from CNS cells (Fig. 2a-c and Supplementary Table 1) . We compared the identified molecular signature of detected genes across all four populations using correspondence analysis (COA) and found 106 genes that were specifically expressed in microglia (Fig. 2d,e) . The purity of CNS cells types was established by qPCR analysis using their known unique markers (Fig. 2f) . qPCR analysis revealed that the microglia unique genes Fcrls, Olfml3, Tmem119, P2ry12, Hexb and Tgfbr1 were not expressed in oligodendrocytes, astrocytes and neurons (Fig. 2g) .
In addition, we analyzed a published database of identified genes in oligodendrocytes, astrocytes and neurons 18 . We compared the identified molecular signature of genes whose expression was increased by more than threefold across all four populations and found 152 genes that were specifically expressed in microglia (Supplementary Table 2 ). Consistent with our results (Fig. 2) , P2ry12, Fcrls, Tmem119, Olfml3, Hexb and Tgfbr1 were identified as unique microglial genes. Thus, these unique microglial genes may serve as targets for further investigations into microglia biology.
To better understand the physiological function of microglia on the basis of our identified molecular signature, we performed ingenuity pathway analysis (IPA). Based on the molecules present in the dataset, IPA analysis revealed that the functions most associated with microglia were related to nervous system development, which we did not observe in monocytes (Supplementary Figs. 2 and 3) . GeneGo analysis identified PU.1 as the most significantly affected transcription factor in microglia (P = 3.76 × 10 −11 ) (Supplementary Table 3 and Supplementary Fig. 4 ), which confirms previous observations that PU.1-deficient mice do not develop myeloid cells 19, 20 . Finally, canonical pathway ( Supplementary  Fig. 5 ) and upstream regulator analysis (Supplementary Table 4 ) revealed that TGF-β was among the most affected molecules in microglia (Supplementary Fig. 6 ). These results are consistent with our findings, presented below, that TGF-β is important for the development and maintenance of microglia both in vitro and in vivo.
Identification of a microglial microRNA signature To further characterize microglia, we used a Nanostring-based miRNA chip that contained 600 microRNAs to profile microglia versus immune cells. We found eight microRNAs that were highly expressed in microglia (Fig. 3a) . Three of these (miR-125b-5p, miR-342-3p and miR-99a) were specifically expressed in microglia as compared to other immune cell types. In addition, we identified 24 microRNAs that were highly expressed in Ly6C + inflammatory monocytes and immune cells. Three of these (miR-223, miR-148a and miR-15b) were specifically expressed in Ly6C monocyte subsets (Fig. 3b) . To validate these findings, we performed qPCR analysis of microglial miRNAs (miR-125b-5p, miR-99a and miR-342-3p) and inflammatory Ly6C + miRNAs (miR-15b, miR-148a and miR-223) and found expression pattern similar to the one that we observed by Nanostring (Fig. 3c,d ). To determine whether there was similar expression of microglial and inflammatory monocyte miRNAs in humans, we performed qPCR in both fetal and adult CNS-derived human microglia and human blood-derived CD14 + CD16 − and CD14 + CD16 + monocytes (analogs of Ly6C Hi and Ly6C Low subsets). We found that miR-99a, miR-125b-5p and miR-342-3p were highly expressed in human microglia (Fig. 3c,d) . Consistent with our results in mice, we also found that miR-15b, miR-148a and miR-223 were highly expressed in human monocytes, with miR-223 being the most selectively expressed miRNA.
To investigate whether the microglial miRNAs that we identified were expressed in CNS cells including astrocytes, oligodendrocytes and neurons, we profiled these cells with the Nanostring miRNA chip (Supplementary Fig. 7) . We found that miR-342-3p was enriched in microglia, whereas both miR-125b-5p and miR-99a were highly expressed in microglia, astrocytes and neurons, but not in oligodendrocytes (Supplementary Fig. 7 ).
Identification of unique microglial surface molecules
We identified P2ry12 and Fcrls as unique microglial genes. We therefore studied the surface expression of these molecules by both npg r e S O u r C e fluorescence-activated cell sorting (FACS) and immunohistochemistry. To study P2ry12, we obtained a polyclonal rabbit antibody to P2ry12 that was previously shown to regulate microglial activation 21 and generated a rat antibody to P2ry12. To study FCRLS, we constructed an expression vector to generate an FCRLS-Fc fusion protein and immunized rats to produce a monoclonal antibody to FCRLS. FACS analysis revealed that antibodies to FCRLS and P2ry12 stained adult microglia isolated by conventional methods 22 from naive murine brain, but did not stain CD11b-gated myeloid cells from murine spleen, bone marrow and peripheral blood (Fig. 4a) . In addition, antibody to FCRLS stained >97% of the total CD11b-gated cells in the brain, spinal cord and eye (Fig. 4b) . FACS analysis of human cells showed that antibody to P2ry12 stained a subpopulation of CD14 + myeloid cells isolated from fresh post-mortem brain, but did not stain peripheral blood CD14 + monocytes (Fig. 4c) . No staining of human cells was observed with antibody to FCRLS. Notably, there is no human ortholog of the Fcrls gene.
Immunohistochemical staining of both murine and human brain with antibody to P2ry12 identified cells with a microglia morphology (Fig. 4d) . In addition, the P2ry12 signal colocalized on CX3CR1 GFP microglia in which GFP is expressed in resident microglia 17, 23 (Fig. 4e) .
The P2ry12 signal was not observed on GFAP + astrocytes or NeuN + neurons (Fig. 4f) or on peripheral tissue resident macrophages in splenic red and white pulp, lung, kidney, liver, and skin ( Supplementary  Fig. 8a ). Staining of murine microglia with a polyclonal antibody to FCRLS was observed by FACS ( Supplementary Fig. 8b ) and immunohistochemistry ( Supplementary Fig. 8c,d ). Rat antibody to P2ry12 stained Iba-1 + GFP − resident microglia in naive CX3CR1 GFP/+ chimeric mice, but not recruited Iba-1 + GFP + monocytes (Fig. 4g) .
Recruited monocytes do not acquire the microglia signature To investigate whether antibody to P2ry12 recognized recruited monocytes under inflammatory conditions, we induced EAE in CX3CR1 GFP/+ chimeric mice. Recruited GFP + monocytes did not express P2ry12 and resident GFP − microglia expressed P2ry12 in both naive and EAE mice (Fig. 4h) .
Although the lineage relationship between microglia and macrophages is clear 4, 5 , a major question is whether or not circulating monocytes and/or myeloid progenitor cells can acquire a unique molecular microglia signature and restore microglial function in the healthy CNS and disease. To address this question, we investigated whether Ly6C + recruited monocytes acquire the microglial signature during miRNA signature mmu-miR-338-3p mmu-miR-22 mmu-miR-27a mmu-miR-15a mmu-miR-10a mmu-miR-223 mmu-miR-148a mmu-miR-340-5p mmu-miR-93 mmu-miR-20a/b mmu-miR-25 mmu-miR-15b mmu-let-7i mmu-miR-19a mmu-miR-106a/17 mmu-miR-106b mmu-miR-16 mmu-miR-1944 mmu-miR-30d mmu-miR-26b mmu-miR-142-3p mmu-let-7g mmu-miR-720 mmu-miR-150 mmu-miR-29a mmu-miR-29b mmu-miR-342-3p mmu-miR-103 mmu-miR-99a mmu-miR-322 mmu-miR-125b-5p mmu-miR-30a mmu-miR-142-5p mmu-miR-202-5p mmu-miR-574-5p mmu-miR-205 mmu-miR-674 mmu-miR-762 mmu-miR-682 mmu-miR-129-5p mmu-miR-199a-3p mmu-miR-465a-3p mmu-miR-467e mmu-miR-1894-3p mmu-miR-1893 mmu-miR-100 mmu-miR-290-3p mmu-miR-1898 mmu-miR-151-5p mmu-miR-126-5p mmu-miR-126-3p
Microglia
Immune cells/Ly6C (c,d) qPCR validation of microglial miRNAs (miR-99a, miR-342-3p miR-125b-5p; c) and inflammatory Ly6C + miRNAs (miR-15b, miR-148a, miR-223; d) in Ly6C monocytes, organ-specific macrophages, and human fetal and adult microglia. Data are presented as mean normalized intensity ± s.e.m. (n = 3). miRNA expression level was normalized against U6 miRNA using ∆Ct. One of two individual experiments is shown. npg r e S O u r C e neuroinflammation. Thus, we sorted FCRLS + CD11b + GFP − resident microglia and recruited Ly6C + CD11b + GFP + monocytes from EAE chimeric mice (Fig. 4i) . We found that recruited GFP + Ly6C Hi , GFP + Ly6C Low and GFP + Ly6C Neg monocyte subsets did not acquire the microglia signature during EAE and that FCRLS + CD11b + GFP − resident microglia expressed the microglial signature defined by the MG400 chip (Fig. 4j) . Thus, microglia and recruited monocytes maintain their own molecular signature during neuroinflammation. npg r e S O u r C e signature that we identified to those of microglial cell lines and other microglial preparations to determine the degree to which they expressed a microglial signature. We investigated newborn microglia (postnatal day 1, P1), primary cultured newborn microglia (P1-2), microglial cell lines (N9, BV2), embryonic stem cell microglia (ESdMs) 24 and RAW264.7 macrophages. We found that none of these cells expressed the adult microglia signature that we identified. Hierarchical clustering revealed that freshly sorted newborn and cultured primary microglia were the most similar to adult microglia (Fig. 5a) . We compared the expression of the most highly specific microglial genes that we found to be expressed in adult microglia in vivo to the cell lines that we tested (Fig. 5b) . We then performed qPCR analysis of ten selected microglial genes to validate their expression in different microglial cell lines. We found minimal, if any, expression of these ten genes in microglial cell lines. Of note, Apoe was highly expressed in newborn and primary microglia and had minimal expression in adult microglia (Fig. 5c) . To determine the point at which microglia acquire a microglia signature, we profiled embryonic (E10.5 and E12.5), postnatal (P4, P21 and P30) and adult microglia (2 months). Heat map hierarchical cluster analysis revealed that microglia expressed the lowest level of microglial genes between embryonic (E10.5, E12.5) and postnatal stages (P4; Supplementary Fig. 9 ). The highest level of expression of microglial genes occurred in the second period, between P21 and 2 months of age (Supplementary Fig. 9a,b) . Of note, Apoe expression was downregulated in microglia during development and expression of Apoe reciprocally correlated with the induction of microglial genes (Supplementary Fig. 9c ).
TGF-b is required for development of microglia in vitro
Using the microglia signature that we identified, we investigated factors responsible for the growth and development of microglia in vitro. We cultured adult microglia in the presence of GM-CSF or MCSF with or without the addition of TGF-β1. TGF-β1 and MCSF treatment induced an increase by more than twofold in the expression of 60 microglial genes as compared with microglia cultured in the presence of MCSF alone and 108 microglial genes as compared with microglia cultured in the presence of GM-CSF (Fig. 6a) . We termed these microglia 'M0' , as their phenotype resembled that of freshly isolated adult microglia. Adult microglia did not survive in the presence of TGF-β1 alone and no effect was observed when TGF-β1 was added to GM-CSF. We found that 19 genes, mostly related to pro-inflammatory responses, including Ccl2 and Ccl3, were suppressed when microglia were cultured with MCSF or MCSF and TGF-β1 (Fig. 6b) . The expression of six selected microglial genes in microglia cultured with MCSF and TGF-β1 was confirmed by qPCR (Fig. 6c) npg r e S O u r C e in the presence of MCSF and TGF-β1 most closely resembled freshly sorted adult microglia (Fig. 6d) . Of note, MCSF and TGF-β1 did not induce the expression of microglial genes (Fig. 6e) or microglial miRNAs (Fig. 6f) in either the N9 microglia cell line or the RAW264.7 macrophage cell line. Consistent with our findings, others have reported that TGF-β1 signaling in vitro induces a quiescent microglial phenotype 25 and promotes resting microglial properties 26 . 
Sall1
Expression level (a.u.) One of three individual experiments is shown. (c) qPCR analysis of six selected microglial genes in cultured adult microglia in the presence of MCSF and TGF-β1. Gene expression level was normalized against Gapdh using ∆Ct (n = 6, each biological triplicate consisted of two wells per treatment). Data are presented as mean normalized intensity ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001 (F 2,15 = 5.829, one-way ANOVA followed by Dunnett's multiple-comparison post hoc test). (d) PCA of different cell populations based on MG400 expression profile. (e,f) qPCR analysis of Fcrls, Sall1 and Gpr34 gene expression (e) and miR-99a, miR-125b-5p and miR-342-3p expression (f) in RAW264.7 macrophages, N9 microglia cell line and adult microglia cultures. Cells were untreated or cultured in the presence of MCSF, GM-CSF, or polarized for 48 h to M0 (MCSF + TGF-β1), M1 (GM-CSF + IFNγ/LPS) or M2 (MCSF + IL4) phenotypes. RAW264.7 macrophages and N9 cells survived without MCSF or GM-CFS, whereas adult microglia required either MCSF or GM-CSF. Gene expression level was normalized against Gapdh using ∆Ct (n = 3). miRNA expression level was normalized against U6 miRNA using ∆Ct (n = 3). Data are presented as mean ± s.e.m. Shown is one of two individual experiments.
r e S O u r C e
In addition, we investigated the MG400 profile in GM-CSFcultured microglia with either LPS and IFN-γ or MCSF and IL4, which are known to polarize M1 and M2 microglia, respectively 27 ( Supplementary Fig. 10 ). We found that M1 microglia expressed a high level of inflammatory-related transcripts, including Ccl2, Ccl3 and Ccl5, whereas M2 microglia expressed genes, including Igf1 (Supplementary Fig. 10a,b) , that are involved in tissue development and neural cell renewal 28 . To better understand the physiological function of M0-versus M1-and M2-polarized microglia, we performed IPA analysis on the basis of the identified affected microglial genes. We found that microglial functions in M0-polarized microglia were related to nervous system development and were not observed in M1-or M2-polarized microglia (Supplementary Fig. 10c) . In addition, GeneGo analysis showed that the major upstream regulators in M0 microglia were related to TGFβ-1 signaling. (Supplementary  Fig. 10d ). It should be noted, however, that the regulators of M1 and M2 phenotypes were not found in the intact CNS and that freshly isolated microglia from naive and diseased mice did not demonstrate these expression profiles.
TGF-b is critical for microglia development in vivo
Investigation of TGF-β1 in the adult mouse brain has been limited, as Tgfb1 −/− mice develop a lethal auto-inflammatory syndrome shortly after birth 29, 30 that is linked to a T cell-specific deficiency of TGF-β (ref. 31) . We previously generated a TGF-β1 transgenic mouse in which the Tgfb1 gene is linked to the Il2 promoter (Il2-Tgfb1) and T cells transiently overexpress TGF-β after TCR stimulation 32 . We crossed this Il2-Tgfb1 mouse with Tgfb1 −/− mice. Intercrossing these mice generated Il2-Tgfb1; Tgfb1 −/− mice, which bear the transgenic Tgfb1 gene, but lack both endogenous Tgfb1 alleles. In Il2-Tgfb1; Tgfb1 −/− mice, the expression of TGF-β1 is therefore limited to T lymphocytes. We found that Il2-Tgfb1; Tgfb1 −/− mice were protected from lethal inflammation, survived into adulthood and were indistinguishable from Il2-Tgfb1; Tgfb1 +/− littermates at the age of 4-10 weeks, with no signs of inflammation or organ dysfunction. However, when we investigated the CNS of these mice, we found that they did not express TGF-β1 in the brain or spinal cord and we found no TGF-β1-producing T cells in the CNS 33 . These mice have defects in extracellular glutamate homeostasis and synaptic plasticity 33 and we refer to them as CNS Tgfb1 −/− mice. These mice therefore provide a unique opportunity to investigate the effects of TGF-β1 deficiency in the CNS on microglia.
We found a loss of microglial cells in the CNS of adult CNS Tgfb1 −/− mice, as measured by immunohistochemistry with antibody to P2ry12 at 20 and 90 d of age and in Tgfb1 −/− mice just prior to death at 20 d (Fig. 7a) . Iba-1 staining (Fig. 7b) and quantitative analysis of Iba-1 + myeloid cells revealed a reduced number of Iba-1 + cells in CNS Tgfb1 −/− mice (Fig. 7c) , and these cells had a round morphology without ramified processes as compared with wild-type mice (Fig. 7b) . We did not observe neuronal loss in either CNS Tgfb1 −/− or Tgfb1 −/− mice (Fig. 7b,c) . FACS analysis with antibody to FCRLS at 20 and 90 d of age (Fig. 7d) and quantitative analysis of FCRLS + CD11b + cells at 20, 90 and 160 d revealed a loss of FCRLS + microglia in CNS Tgfb1 −/− mice (Fig. 7e) . In addition, CD11b + CD45 Low microglia were lost in CNS Tgfb1 −/− mice (Supplementary Fig. 11a ). We also found increased apoptosis of CD39 + CD11b + cells at 20, 90 and 160 d of age ( Supplementary  Fig. 11b,c) . We then investigated the expression of F4/80 at 90 d in CNS Tgfb1 −/− mice; F4/80 stains organ-specific macrophages and microglia 5, 34 . We found that there was a significant reduction (P < 0.001) in the number of of F4/80 + CD11b + cells as compared with wild-type mice and that the level of CD11b expression was reduced in CNS Tgfb1 −/− mice (Fig. 7f) . We previously reported that CD39 is expressed on adult microglia and its expression can be used to distinguish recruited Ly6C + monocytes from resident microglia 12 . In CNS Tgfb1 −/− mice, we found that the number of CD39 + CD11b Low cells was decreased in a fashion identical to that of F4/80 + CD11b Low cells (Fig. 7f,g) . Associated with this, we found an increase in the number of CD39 − CD11b Hi cells that expressed Ly6C (Fig. 7g) and that represented peripherally infiltrating monocytes 9, 12 . Quantitative analysis showed a significant reduction (P < 0.001) in the number of CD39 + CD11b + cells and a reciprocal increase in the number of Ly6C + CD11b + cells at 20, 90 and 160 d in CNS Tgfb1 −/− mice (Fig. 7h) . Notably, it has been reported that endogenous TGF-β1 is essential for normal murine Langerhans cell development 35 , and TGF-β1 acts directly on Langerhans cells through an autocrine/paracrine loop 36 . However, we did not find differences in peripheral organ macrophages, dendritic cells or Langerhans cells in CNS Tgfb1 −/− mice (Supplementary Fig. 12) , consistent with the fact that the loss of TGF-β1 is restricted to the CNS.
It is known that, in mice, the earliest developmental stage at which seeding of cells in the brain with myeloid features occurs is E8.5-9.0 (ref. 37) . Subsequent studies have found that microglia arise early during development from progenitors in the embryonic yolk sac 4, 38, 39 . Thus, primitive macrophages exit the yolk sac blood islands at the onset of circulation and colonize the neuroepithelium from E9.5 to give rise to microglia. The blood-brain barrier begins to form at E13.5 and may isolate the developing brain from the contribution of fetal liver hematopoiesis 40 . We found no difference in the number of CD39 + CD11b + cells between wild-type and CNS Tgfb1 −/− mice at E10.5 (Supplementary Fig. 13 ). At E14.5, however, we found a substantial reduction in the number of CD39 + CD11b + cells (from 82.7% to 14.7%), which was associated with reduced surface expression of CD11b. In addition, at E14.5, we found an increase in the number of CD39 − CD11b + cells (from 6.8% to 44.5%). The same pattern was observed in newborn brains (P1). At 160 d of age, we found that CD39 + CD11b Low cells were absent in CNS Tgfb1 −/− mice, and this was associated with a concomitant increase in the number of CD39 − CD11b + Ly6C + cells (Fig. 7h and  Supplementary Fig. 13a ). We did not find a change in the number of F4/80 + CD11b + primitive macrophages in the yolk sac at E10.5 ( Supplementary Fig. 13b,c) .
CNS Tgfb1 −/− mice developed normally until they reached 100-120 d of age, at which point they developed motor abnormalities (Supplementary Movie 1) , as measured by decreased body weight and reduced rotarod performance (Fig. 7i) . These mice steadily progressed to paralysis and death by 23-25 weeks of age. We also observed microglia loss in the spinal cord of CNS Tgfb1 −/− mice; the number of neurons was not affected (Supplementary Fig. 14) . Thus, apart from the physiologic changes described previously 33 , the only morphological change in the brains of CNS Tgfb1 −/− mice was the loss of microglia.
To determine whether the remaining CD39 + Ly6C − CD11b Low cells in the CNS of CNS Tgfb1 −/− mice were resident microglia that expressed the microglial molecular signature, we profiled them using the MG400 chip. We sorted CD39 + Ly6C − CD11b + cells by FACS from both CNS Tgfb1 −/− and wild-type mice. We found that, at 60 d of age, CD39 + Ly6C − CD11b + cells from CNS Tgfb1 −/− mice only expressed low levels of microglial genes and that recruited CD39 − CD11b Hi cells did not express any microglial genes (Fig. 8a,b) . qPCR analysis revealed that microglial gene expression was absent (Fig. 8c) . Of note, the expression of Apoe was markedly increased in CD39 + Ly6C − CD11b + cells from CNS Tgfb1 −/− mice (Fig. 8c) . Expression of the microglia-specific miRNAs miR-99a, miR-125b-5p and miR-342-3p was markedly decreased in CD39 + Ly6C − CD11b + cells (Fig. 8d) . We then npg r e S O u r C e investigated the expression of microglial genes during development in CNS Tgfb1 −/− mice. We found that P2ry12, Sall1 and Fcrls expression was markedly decreased in microglia from CNS Tgfb1 −/− mice at E14.5 and that P2ry12 and Sall1 transcripts were undetectable at P1.
Notably, there was increased expression of Apoe at both E14.5 and P1 (Fig. 8e) . IPA analysis of canonical pathway and upstream regulator analysis (Supplementary Fig. 5 and Supplementary Table 4 , respectively) based on the expression of microglial genes (Fig. 8a npg r e S O u r C e revealed that TGF-β pathway and downstream microglial proteins, which we identified as the most affected proteins in microglia, were suppressed in CNS Tgfb1 −/− mice (Supplementary Fig. 15 ). In summary, the lack of TGF-β1 affected microglial development beginning at E14.5, but did not affect microglial progenitors at the E10.5 stage.
DISCUSSION
Using a multifaceted approach, we identified a unique genetic and microRNA signature for both mouse and human microglia cells that distinguishes microglia in the CNS from peripheral monocytes and other immune cells and from other cells of the nervous system. The plasticity of cell populations remains a major feature of cell lineages, Expression levels were normalized to Gapdh. Data are presented as mean ± s.e.m. (n = 3 mice per group; P2ry12, P < 0.0001, F 2,9 = 335.5; Fcrls, P < 0.0001, F 2,9 = 221.5; Sall1, P < 0.0001, F 2,9 = 69.4; Itgb5, P < 0.0001, F 2,9 = 102.0; Mertk, P < 0.0001, F 2,9 = 234.8; Gpr34, P < 0.0001, F 2,9 = 71.5; Pros1, P = 0.002, F 2,9 = 24.2; C1qa, P < 0.0001, F 2,9 = 93.4; Apoe, P < 0.0001, F 2,9 = 110.8; one-way ANOVA followed by Dunnett's multiple-comparison post hoc test). (e) qPCR validation of four selected microglial genes at E14.5 (n = 4) and P1 (n = 5) mice. Data are presented as mean ± s.e.m. (P2ry12: E14.5, P < 0.0001, t = 11.91; P1, P < 0.0001, t = 18.48; Fcrls: E14.5, P = 0.035, t = 3.66; P1, P < 0.006, t = 5.26; Sall1: E14.5, P < 0.0001, t = 18.38; P1, P = 0.0034, t = 6.24; Apoe: E14.5, P = 0.0221, t = 2.97; P1, P = 0.0088, t = 3.62; Student's t test, unpaired). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
npg r e S O u r C e including T cells and neurons. A similar plasticity exists in microglia, which are clearly more diverse than an M1 or M2 classification. On the basis of the microglial molecular signature that we identified, we were able to define the plasticity of microglia and the factors in vivo and in vitro that affect them. We identified TGF-β1 as a major differentiation factor for microglia both in vitro and in vivo. Consistent with this, we found a loss of microglia in mice deficient for TGF-β1 in the CNS. Although there was no overt neuronal loss in CNS Tgfb1 −/− mice, these mice developed late onset motor dysfunction. Previously, we found that these mice have defects related to glutamate recycling and synaptic plasticity 33 . Consistent with this, deficits in microglia function have been reported to contribute to synaptic abnormalities that may be present in neurodevelopmental disorders 41 . CNS Tgfb1 −/− mice appeared to show a healthy behavior phenotype throughout much of their adult life. This observation raises the possibility that other cells assume some of the functions of resident microglia at earlier stages of life, such as synaptic pruning during early brain development. Detailed neuromorphological and behavioral analysis will be required to determine the extent to which abnormalities of microglia alter neurodevelopment and to define which cell types might compensate.
TGF-β and its receptor are expressed at low levels by both neurons and glial cells 42, 43 , and their expression is upregulated in response to a wide range of neuronal insults and during aging 44, 45 . We observed high expression of Tgfb1 and Tgfbr1 in microglia (Fig. 1f) . Numerous studies have found that TGF-β1 exerts a protective effect against various neuronal insults 46 .
Tgfb1 −/− mice die at 3 weeks of age as a result of a severe multifocal auto-inflammatory disorder 30 , and it has been reported that the loss of TGF-β1 in these mice leads to increased neuronal cell death and microgliosis in the brain 47 . In these studies, microglia were identified as F4/80 + cells, which does not distinguish resident microglia from infiltrating macrophages. Using our microglial-specific markers and molecular signature, we found that there was a loss of microglia, as opposed to microgliosis, and that this loss was associated with infiltration of Ly6C + monocytes into the brain.
Because we identified genes related to neuronal function in both cultured and ex vivo adult microglia, the presence of these genes does not simply represent extracellular absorption, as the microglial genes that we identified were upregulated by exogenous TGF-β1 in vitro. In addition to the known innate immune function of microglia, IPA identified neuronal and development function as the most substantially expressed pathways in microglia. Our results are consistent with previous studies on the role of microglial in the development and function of the nervous system 41, [48] [49] [50] .
We found that microglia have different phenotypes that are linked to development. Thus, embryonic and early postnatal microglia acquired the features of adult microglia after P4, possibly as newly proliferated microglial cells began to express differentiated functions. Commonly studied microglia cell lines and primary microglia did not express the adult microglial molecular signature and did not express the signature after culture with TGF-β1. The identification of a molecular microglial signature can now be used to determine the features that account for microglia CNS homeostatic function, as well as neurotoxic versus protective properties. We also found that organ-resident macrophages in the gut and liver were 'microglia-like' , as they expressed Gas6 and Mertk and these genes may be involved in maintaining tissue homeostasis, which is consistent with a recent transcriptional profiling of murine tissue macrophages 14 .
In summary, we identified a TGFβ-1-dependent microglial signature and structures on the surface of microglia that provide the ability to distinguish microglia from infiltrating myeloid cells in the CNS. The genetic and microRNA signature that we observed in mice was also found in human microglia. These findings provide new insights into microglial biology and the possibility of targeting microglia for the treatment of CNS disease.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The gene and miRNA data have been deposited in Gene Expression Omnibus (GEO) database under the accession number GSE48579 and protein data has been deposited in PeptideAtlas under the accession code PASS00352. 
ONLINE METhODS
Mice. C57BL6 males and females, B6.Cg-Tg were obtained from Jaxmice laboratories. Adult male and female heterozygous Tgfb1 −/+ mice were kindly provided by S.M. Wahl (US National Institutes of Health). These mice were kept on C57BL6/Sv129 background. On the C57BL6/Sv129 background, 60-80% of (statistically expected) homozygous Tgfb1 −/− conceptuses reached parturition as described 29 . C57BL/6 IL2 transgenic mice that express TGF-β1 under the control of the Il2 promoter were generated in our laboratory and are described elsewhere 32 . Those mice were crossed with Tgfb1 −/+ animals to obtain Il2-Tgfb1; Tgfb1 +/− mice. Il2-Tgfb1; Tgfb1 +/− mice do not show any clinical or pathological abnormalities and breed well. Progeny mice were intercrossed at least six generations before all experimental procedures, and Il2-Tgfb1; Tgfb1 −/− mice were generated from crossing heterozygous Il2-Tgfb1; Tgfb1 +/− mice 33 . All experiments were performed in mice with a mixed inbred genetic background (75% C57BL6 and 25% Sv129). Because Tgfb1 −/− mice are not viable on a 100% C57BL6 background 29 , we refrained from backcrossing them. Heterozygous Il2-Tgfb1; Tgfb1 +/− mice were used as a littermate control mice for Il2-Tgfb1; Tgfb1 −/− mice. All mice were housed with sterile food and water ad libitum. Mice were killed by CO 2 inhalation. The Institutional Animal Care and Use Committee at Harvard Medical School approved all experimental procedures involving animals.
generation of chimeric mice. Recipient lethally irradiated (950 Rad) 30-d-old C57BL/6 mice were transplanted with donor syngeneic bone marrow cells from CX3CR1-GFP +/− -wild-type mice. In these chimeras, peripheral monocytes are distinguishable from microglia by FACS 12 . We determined the percentage of chimerism 8 weeks after transplant by examining cells from the spleen. We found that 95-97% of F4/80 + CD11b + cells in the spleen were GFP + . In chimeric naive or EAE mice, mononuclear cells stained for the monocyte marker CD11b could be easily subdivided into two distinct subsets: CD11b + GFP − FCRLS + microglia and CD11b + GFP + FCRLS − peripheral macrophages (Fig. 4i). generation of antibodies to P2ry12 and FcRlS. P2ry12 polyclonal antibody was generated in rats. Adult Lewis rats were vaccinated (intraperitoneal) five times (2 weeks apart) with a synthetic peptide corresponding to the mouse P2Y12 C terminus (NH2-Cys-Gly-Thr-Asn-Lys-Lys-Lys-Gly-Gln-Glu-GlyGly-Glu-Pro-Ser-Glu-Glu-Thr-Pro-Met-OH; Anaspec) 21 . The first vaccination was given with Complete Freund's Adjuvant (CFA) and the next three injections with Incomplete Freund's Adjuvant (IFA) combined with the synthetic P2ry12 peptide to generate rat antibodies. For the first injection, the peptide was conjugated to Keyhole Limpet Hemocyanin (KLH) plus CFA followed by a second injection with 50 µg of the synthetic peptide conjugated to bovine serum albumin (BSA) and IFA and then a third injection with 50µg of a synthetic peptide conjugated to ovalbumin + IFA. All injections were given intraperitoneal. The above injections were given 2 weeks apart. A fourth injection was given 2 weeks later with 50 µg of the synthetic peptide conjugated to KLH plus Titermax (200µl). The fifth injection was given with 50 µg of the synthetic peptide conjugated to BSA. First three injections were given at a 1:1 ratio with CFA or IFA. CFA, IFA and Titermax were purchased from Sigma. P2ry12 antibody was affinity purified using a Sulfolink coupling gel (Pierce) to immobilize the antigenic peptide.
To generate monoclonal antibody to FCRLS, we constructed an expression vector pFUSE-hIgG2-FC2 (InvivoGen) to generate FCRLS-Fc fused protein.
Adult Lewis rats were vaccinated as described above and identified positive FCRLS 16 oligoclones were subcloned to produce monoclonal antibody to FCRLS. 4G11 FCRLS clone was used in this study.
Mouse microglia isolation and sorting. Mononuclear cells were directly isolated from C57BL6 embryos (E10.5, E12.5), newborn (P4) and adult (P21, P30 and 2 months) mice. Mice were transcardially perfused with ice-cold phosphatebuffer saline (PBS), spinal cords and brains separately dissected. Single cell suspensions were prepared and centrifuged over a 37%/70% discontinuous Percoll gradient (GE Healthcare), mononuclear cells isolated from the interface, and total cell count determined. Isolated cells were labeled with monoclonal antibody to FCRLS to specifically sort resident microglia followed by total RNA isolation and gene/miRNA expression profiling. Resident microglia were sorted with combination of FRCLS and CD11b antibodies. cell suspension preparation. Cell suspensions were made from brain 12 and other tissues as described 51 before analysis by flow cytometry. Yolk sac from mouse embryos was dissected as described 52 and yolk sac cell suspensions were made as described 4 . Skin cell suspensions were isolated as previously described 53 and analyzed by flow Cytometry. In brief, mouse ears were split in two dorsal and ventral parts and incubated for 1 h in Hank's Balanced Salt Solution (HBSS) containing 2.4 mg ml −1 Dispase (working activity = 1.7 U mg −1 ; Invitrogen) to allow for separation of dermal and epidermal sheets. Epidermal and dermal sheets were then cut into small pieces, incubated for 2 h in HBSS containing 1% fetal bovine serum (FBS) and 0.2 mg ml −1 collagenase type IV (working activity of 770 U mg −1 ; Sigma-Aldrich), and then passed through a 19G syringe to obtain homogenous cell suspension. Lung, liver, kidney and spleen cells were isolated, homogenized and incubated for 1 h in 10% FBS HBSS containing 0.2 mg ml −1 collagenase type IV (working activity 0f 770 U mg −1 ), and passed through a 19G syringe to obtain homogeneous cell suspension. Cell suspensions were then run either through a 20-22 °C NycoPrep gradient 1.077 (Axis-Shield; for lung and kidney) and a 20-22 °C isotonic Percoll (GE Healthcare; for liver) centrifugation to enrich the percentage of hematopoietic cells, as per manufacturer's instructions. Resting red-pulp macrophages from the spleen were sorted after nonenzymatic disaggregation of the spleen and were identified as F4/80hi cells that lacked B220 but had high expression of CD11c and MHC class II 14 . A combination of AnnexinV-PE-or AnnexinV-FITC-conjugated and 7AAD-PerCP was used to stain apoptotic and necrotic cells, respectively (BD Biosciences). Appropriate antibody IgG isotype controls (BD Biosciences) were used for all staining. FACS analysis was performed on a LSR machine (BD Biosciences), and data analyzed with FlowJo Software (TreeStar). Cell sorting was performed using a Becton Dickinson FACSARIA cell sorter.
Primary newborn mouse microglial culture. Brains from neonatal (P0-1) C57BL6J mice were stripped of their meninges and minced with scissors under a dissecting microscope (Stemi DV4, Zeiss) in Leibovitz-15 medium (Biological Industries). After trypsinization (0.5% trypsin for 10 min at 37 °C, 5% CO2), the tissue was triturated. The cell suspension was washed in culture medium for glial cells (DMEM supplemented with 10% fetal calf serum (FCS, Sigma-Aldrich), 1 mM l-glutamine, 1 mM sodium pyruvate, 100 U ml −1 penicillin and 100 mg ml −1 streptomycin) and cultured at 37 °C, 5% CO2 in 75-cm 2 Falcon tissue-culture flasks (BD Biosciences) coated with poly-d-lysine (PDL; 10mg ml −1 ; SigmaAldrich) in borate buffer (2.37g borax and 1.55g boric acid dissolved in 500 ml npg
